presents

Cytokinetics Presents Additional Data From GALACTIC-HF at the American Heart Association Scientific Sessions 2024Cytokinetics Presents Additional Data From GALACTIC-HF at the American Heart Association Scientific Sessions 2024

Cytokinetics Presents Additional Data From GALACTIC-HF at the American Heart Association Scientific Sessions 2024

SOUTH SAN FRANCISCO, Calif., Nov. 16, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced new data from post-hoc…

5 months ago
Cytokinetics Presents New Data Relating to Aficamten and Hypertrophic Cardiomyopathy at the American Heart Association Scientific Sessions 2024Cytokinetics Presents New Data Relating to Aficamten and Hypertrophic Cardiomyopathy at the American Heart Association Scientific Sessions 2024

Cytokinetics Presents New Data Relating to Aficamten and Hypertrophic Cardiomyopathy at the American Heart Association Scientific Sessions 2024

Two New Analyses from SEQUOIA-HCM Demonstrate Treatment with Aficamten Improves Post-Exercise Oxygen Uptake Recovery and Quality of Life New Data…

5 months ago
Precede Biosciences Presents New Data at AACR LBx 2024 Demonstrating an Accurate Readout of Tumor PSMA Expression and Stratification of Response to Lutetium-PSMA in Men with mCRPC from a Simple Blood TestPrecede Biosciences Presents New Data at AACR LBx 2024 Demonstrating an Accurate Readout of Tumor PSMA Expression and Stratification of Response to Lutetium-PSMA in Men with mCRPC from a Simple Blood Test

Precede Biosciences Presents New Data at AACR LBx 2024 Demonstrating an Accurate Readout of Tumor PSMA Expression and Stratification of Response to Lutetium-PSMA in Men with mCRPC from a Simple Blood Test

Results show the potential of a real-time, non-invasive blood test to quantify tumor drug target expression and to stratify therapeutic…

5 months ago
RMZ Foundation presents Mouna Rebeiz’s artwork at Art MumbaiRMZ Foundation presents Mouna Rebeiz’s artwork at Art Mumbai

RMZ Foundation presents Mouna Rebeiz’s artwork at Art Mumbai

Art Mumbai at Mahalaxmi Racecourse is scheduled to open from November 14th to 17th, 2024 MUMBAI, India, Nov. 14, 2024…

5 months ago

Automobili Lamborghini presents the Revuelto Opera Unica at Esperienza Arte in Shanghai

Handcrafted artwork showcases the limitless possibilities of Lamborghini’s Ad Personam customization programShanghai, 10 November 2024 – Automobili Lamborghini unveiled the…

5 months ago

Automobili Lamborghini presents the Revuelto Opera Unica at Esperienza Arte in Shanghai

Handcrafted artwork showcases the limitless possibilities of Lamborghini’s Ad Personam customization programShanghai, 10 November 2024 – Automobili Lamborghini unveiled the…

5 months ago

Automobili Lamborghini presents the Revuelto Opera Unica at Esperienza Arte in Shanghai

Handcrafted artwork showcases the limitless possibilities of Lamborghini’s Ad Personam customization programShanghai, 10 November 2024 – Automobili Lamborghini unveiled the…

5 months ago

Automobili Lamborghini presents the Revuelto Opera Unica at Esperienza Arte in Shanghai

Handcrafted artwork showcases the limitless possibilities of Lamborghini’s Ad Personam customization programShanghai, 10 November 2024 – Automobili Lamborghini unveiled the…

6 months ago
Replimune Presents Late-Breaking Abstract Featuring Data from IGNYTE Clinical Trial of RP1 Combined with Nivolumab in Anti-PD1 Failed Melanoma at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2024)Replimune Presents Late-Breaking Abstract Featuring Data from IGNYTE Clinical Trial of RP1 Combined with Nivolumab in Anti-PD1 Failed Melanoma at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2024)

Replimune Presents Late-Breaking Abstract Featuring Data from IGNYTE Clinical Trial of RP1 Combined with Nivolumab in Anti-PD1 Failed Melanoma at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2024)

November 09, 2024 13:00 ET | Source: Replimune Group Inc Oral presentation highlighting IGNYTE primary analysis data shows anti-tumor activity…

6 months ago
Ultragenyx Presents Positive Update on GTX-102 Angelman Syndrome Program at FASTs 17th Annual Global Science SummitUltragenyx Presents Positive Update on GTX-102 Angelman Syndrome Program at FASTs 17th Annual Global Science Summit

Ultragenyx Presents Positive Update on GTX-102 Angelman Syndrome Program at FASTs 17th Annual Global Science Summit

November 09, 2024 10:30 ET | Source: Ultragenyx Pharmaceutical Inc. Phase 1/2 data show improvements across all domains and confirm…

6 months ago